Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
JCV test stratifies PML risk in antibody-positive MS
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Multiple sclerosis: genetics, biomarkers, treatments.
Disc swelling and mild initial visual acuity loss predict a better short-term visual acuity outcome in bilateral acute optic neuritis.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Acute disseminated encephalomyelitis after tetanus vaccination of a pregnant woman in Senegal.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Bioinformatics challenges for genome-wide association studies.
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
The role of microglial activation in disease progression.
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.

Pages